These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 33609804)
1. Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data. Xu C; Yi Z; Cai R; Chen R; Thong BY; Mu R Autoimmun Rev; 2021 Apr; 20(4):102778. PubMed ID: 33609804 [TBL] [Abstract][Full Text] [Related]
2. Risk and clinical outcomes of COVID-19 in patients with rheumatic diseases compared with the general population: a systematic review and meta-analysis. Wang Q; Liu J; Shao R; Han X; Su C; Lu W Rheumatol Int; 2021 May; 41(5):851-861. PubMed ID: 33687528 [TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis. Wang F; Ma Y; Xu S; Liu H; Chen Y; Yang H; Shao M; Xu W; Kong J; Chen L; Xu S; Shuai Z; Pan F Clin Rheumatol; 2022 Jul; 41(7):2213-2223. PubMed ID: 35352217 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 Infection and COVID-19 Outcomes in Rheumatic Diseases: A Systematic Literature Review and Meta-Analysis. Conway R; Grimshaw AA; Konig MF; Putman M; Duarte-García A; Tseng LY; Cabrera DM; Chock YPE; Degirmenci HB; Duff E; Egeli BH; Graef ER; Gupta A; Harkins P; Hoyer BF; Jayatilleke A; Jin S; Kasia C; Khilnani A; Kilian A; Kim AHJ; Lin CMA; Low C; Proulx L; Sattui SE; Singh N; Sparks JA; Tam H; Ugarte-Gil MF; Ung N; Wang K; Wise LM; Yang Z; Young KJ; Liew JW; Grainger R; Wallace ZS; Hsieh E; Arthritis Rheumatol; 2022 May; 74(5):766-775. PubMed ID: 34807517 [TBL] [Abstract][Full Text] [Related]
5. COVID-19 in Patients With Rheumatic Diseases: Is There a Need to Worry? Sachdeva S; Manaktala P; Malik FA; Gupta U; Desai R J Clin Rheumatol; 2022 Mar; 28(2):e401-e406. PubMed ID: 33902097 [TBL] [Abstract][Full Text] [Related]
6. Sociodemographic and clinical factors associated with poor COVID-19 outcomes in patients with rheumatic diseases: data from the SAR-COVID Registry. Isnardi CA; Roberts K; Saurit V; Petkovic I; Báez RM; Quintana R; Tissera Y; Ornella S; D Angelo Exeni ME; Pisoni CN; Castro Coello VV; Berbotto G; Haye Salinas MJ; Velozo E; Reyes Torres ÁA; Tanten R; Zelaya MD; Gobbi C; Alonso CG; de Los Ángeles Severina M; Vivero F; Paula A; Cogo AK; Alle G; Pera M; Nieto RE; Cosatti M; Asnal C; Pereira D; Albiero JA; Savio VG; Maldonado FN; Gamba MJ; Germán NF; Baños A; Gallino Yanzi J; Gálvez Elkin MS; Morbiducci JS; Martire MV; Maldonado Ficco H; Schmid MM; Villafañe Torres JA; de Los Ángeles Correa M; Medina MA; Cusa MA; Scafati J; Agüero SE; Lloves Schenone NM; Soriano ER; Graf C; Pons-Estel BA; Gomez G; Landi M; De la Vega MC; Pons-Estel GJ; Clin Rheumatol; 2023 Feb; 42(2):563-578. PubMed ID: 36201124 [TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of COVID-19 patients with underlying rheumatic diseases in Japan: data from a multicenter observational study using the COVID-19 Global Rheumatology Alliance physician-reported registry. Kihara M; Sugihara T; Asano J; Sato M; Kaneko H; Muraoka S; Ohshima S; Nanki T Clin Rheumatol; 2022 Dec; 41(12):3661-3673. PubMed ID: 35974224 [TBL] [Abstract][Full Text] [Related]
8. Association of Race and Ethnicity With COVID-19 Outcomes in Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance Physician Registry. Gianfrancesco MA; Leykina LA; Izadi Z; Taylor T; Sparks JA; Harrison C; Trupin L; Rush S; Schmajuk G; Katz P; Jacobsohn L; Hsu TY; D'Silva KM; Serling-Boyd N; Wallwork R; Todd DJ; Bhana S; Costello W; Grainger R; Hausmann JS; Liew JW; Sirotich E; Sufka P; Wallace ZS; Machado PM; Robinson PC; Yazdany J; Arthritis Rheumatol; 2021 Mar; 73(3):374-380. PubMed ID: 33146001 [TBL] [Abstract][Full Text] [Related]
9. Global Impact of Coronavirus Disease 2019 Infection Requiring Admission to the ICU: A Systematic Review and Meta-analysis. Tan E; Song J; Deane AM; Plummer MP Chest; 2021 Feb; 159(2):524-536. PubMed ID: 33069725 [TBL] [Abstract][Full Text] [Related]
10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
11. Clinical course and outcomes of COVID-19 in rheumatic disease patients: a case cohort study with a diverse population. Arleo T; Tong D; Shabto J; O'Keefe G; Khosroshahi A Clin Rheumatol; 2021 Jul; 40(7):2633-2642. PubMed ID: 33420870 [TBL] [Abstract][Full Text] [Related]
12. COVID-19 Outcomes in Patients With Systemic Autoimmune Rheumatic Diseases Compared to the General Population: A US Multicenter, Comparative Cohort Study. D'Silva KM; Jorge A; Cohen A; McCormick N; Zhang Y; Wallace ZS; Choi HK Arthritis Rheumatol; 2021 Jun; 73(6):914-920. PubMed ID: 33305544 [TBL] [Abstract][Full Text] [Related]
13. Temporal trends in COVID-19 outcomes in people with rheumatic diseases in Ireland: data from the COVID-19 Global Rheumatology Alliance registry. Conway R; Nikiphorou E; Demetriou CA; Low C; Leamy K; Ryan JG; Kavanagh R; Fraser AD; Carey JJ; O'Connell P; Flood RM; Mullan RH; Kane DJ; Ambrose N; Stafford F; Robinson PC; Liew JW; Grainger R; McCarthy GM; Rheumatology (Oxford); 2022 Jun; 61(SI2):SI151-SI156. PubMed ID: 35258593 [TBL] [Abstract][Full Text] [Related]
14. COVID-19 outcomes among rheumatic disease patients in Kuwait: Data from the COVID-19 Global Rheumatology Alliance (C19-GRA) physician registry. Abutiban F; Saleh K; Hayat S; Tarakmah H; Al-Herz A; Ghanem A Int J Rheum Dis; 2022 Jul; 25(7):743-754. PubMed ID: 35543332 [TBL] [Abstract][Full Text] [Related]
15. Differences in Outcomes and Factors Associated With Mortality Among Patients With SARS-CoV-2 Infection and Cancer Compared With Those Without Cancer: A Systematic Review and Meta-analysis. Khoury E; Nevitt S; Madsen WR; Turtle L; Davies G; Palmieri C JAMA Netw Open; 2022 May; 5(5):e2210880. PubMed ID: 35532936 [TBL] [Abstract][Full Text] [Related]
17. Ethnic minority status as social determinant for COVID-19 infection, hospitalisation, severity, ICU admission and deaths in the early phase of the pandemic: a meta-analysis. Agyemang C; Richters A; Jolani S; Hendriks S; Zalpuri S; Yu E; Pijls B; Prins M; Stronks K; Zeegers MP BMJ Glob Health; 2021 Nov; 6(11):. PubMed ID: 34740916 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and Associated Risk Factors of Mortality Among COVID-19 Patients: A Meta-Analysis. Noor FM; Islam MM J Community Health; 2020 Dec; 45(6):1270-1282. PubMed ID: 32918645 [TBL] [Abstract][Full Text] [Related]
19. Clinical outcomes of COVID-19 patients with rheumatic diseases: a retrospective cohort study and synthesis analysis in Wuhan, China. Qi G; Wang H; Guo Y; Peng C; Zhang C; Chen T; He J; Jin Z Clin Rheumatol; 2022 Jun; 41(6):1899-1910. PubMed ID: 35171364 [TBL] [Abstract][Full Text] [Related]
20. Trends in severe outcomes in SARS-CoV-2-positive hospitalized patients with rheumatic diseases: a monocentric observational and case-control study in northern Italy. Ughi N; Bernasconi DP; Gagliardi C; Del Gaudio F; Dicuonzo A; Maloberti A; Giannattasio C; Rossetti C; Valsecchi MG; Epis OM Reumatismo; 2023 Jul; 75(2):. PubMed ID: 37462130 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]